1
1
1
1
2
2
1
1
2
2
1
1
3
3
2
2
8
8
2
2
2015
2002
Company (27)University (1)
1 - 10 of 27
Sort by
Patent
Publication NumberTW I486169 BFiling StatusIssued PatentAvailabilityUnknownFiling Date2008-04-18Publication Date2015-06-01
What is provided is a method of treating a patient having a tumor comprising administering an effective amount of adenosine deaminase, preferably polyalkylene oxide conjugated, to a patient in need thereof.
Patent
Publication NumberHR P20140947 T1Filing StatusOtherAvailabilityUnknownFiling Date2014-10-01Publication Date2015-02-13
What is provided is a method of treating a patient having a tumor comprising administering an effective amount of adenosine deaminase, preferably polyalkylene oxide conjugated, to a patient in need thereof.
Patent
Publication NumberIL 195168 AFiling StatusPatent ApplicationAvailabilityUnknownFiling Date2008-11-09Publication Date2014-12-31
The invention provides a recombinant Escherichia coli host cell for producing an Escherichia coli-asparaginase II enzyme. The host cell includes an Escherichia coli chromosome and at least one copy of a recombinant extrachromosomal vector, wherein the recombinant extrachromosomal vector encodes the L-asparaginase II enzyme, wherein the host cell chromosome also encodes the same L-asparaginase II enzyme, and wherein the host chromosome does not encode any other isoform of L-asparaginase II.
Patent
Publication NumberPT 2147122 EFiling StatusOtherAvailabilityUnknownFiling Date2008-04-18Publication Date2014-10-15
What is provided is a method of treating a patient having a tumor comprising administering an effective amount of adenosine deaminase, preferably polyalkylene oxide conjugated, to a patient in need thereof.
Patent
Publication NumberES 2507508 T3Filing StatusOtherAvailabilityUnknownFiling Date2008-04-18Publication Date2014-10-15
What is provided is a method of treating a patient having a tumor comprising administering an effective amount of adenosine deaminase, preferably polyalkylene oxide conjugated, to a patient in need thereof.
Patent
Publication NumberDK 2147122 T3Filing StatusOtherAvailabilityUnknownFiling Date2008-04-18Publication Date2014-10-13
What is provided is a method of treating a patient having a tumor comprising administering an effective amount of adenosine deaminase, preferably polyalkylene oxide conjugated, to a patient in need thereof.
Patent
Publication NumberEP 2147122 B1Filing StatusIssued PatentAvailabilityUnknownFiling Date2008-04-18Publication Date2014-07-16
Patent
Publication NumberUS 8741283Filing StatusIssued PatentAvailabilityUnknownFiling Date2008-04-18Publication Date2014-06-03
What is provided is a method of treating a patient having a tumor comprising administering an effective amount of adenosine deaminase, preferably polyalkylene oxide conjugated, to a patient in need thereof.
Patent
Publication NumberTW I427148 BFiling StatusIssued PatentAvailabilityUnknownFiling Date2007-06-26Publication Date2014-02-21
The invention provides a recombinant Escherichia coli host cell for producing an Escherichia coli-asparaginase II enzyme. The host cell includes an Escherichia coli chromosome and at least one copy of a recombinant extrachromosomal vector, wherein the recombinant extrachromosomal vector encodes the L-asparaginase II enzyme, wherein the host cell chromosome also encodes the same L-asparaginase II enzyme, and wherein the host chromosome does not encode any other isoform of L-asparaginase II.
Patent
Publication NumberHK 1142639 A1Filing StatusIssued PatentAvailabilityUnknownFiling Date2010-09-27Publication Date2014-02-14
A mutein recombinant adenosine deaminase having any oxidizable cysteine residue replaced by a non-oxidizable amino acid residue is disclosed. Stabilized recombinant adenosine deaminase, polymer conjugates and methods of treatment using the same are also disclosed.
We found 27 documents that match your Search
Patents: 27

Wellspring Search is the world's most comprehensive collection of enriched content about emerging and licensable technology innovations.


Already a member? Sign in